United States
Vancomycin Injection, USP in 5% Dextrose, 500mg/100 mL in GALAXY Plastic Container. Frozen Premix.
Product Characteristics
| Trademark: | Baxter and Galaxy are trademarks of Baxter International Inc., or its subsidiaries. |
| Container Type: | GALAXY |
| Volume: | 100 ML |
| Drug Class: | Anti-Infective |
| Dosage Form: | Frozen |
| Diluent: | Dextrose |
| Strength: | 500 mg/100 mL |
| Concentration: | 5 mg/mL |
| Shelf Life from manufacture: | 12 months |
| Contains Preservative: | No |
| Storage Recommendations: | Store at or below -20°C (-4°F). The thawed solution remains chemically stable for 72 hours at room temperature (25°C/77°F) or for 30 days under refrigeration (5°C/41°F). Do not refreeze. |
| Rx Only: | Yes |
| Package Insert Link: | baxterpi.com/pi-pdf/Vanco(..) |
Carton
| Length: | 12 IN |
| Width: | 6.2 IN |
| Height: | 3 IN |
| Volume: | 0.13 FC |
| Weight: | 3.5 LB |
| Pack Factor: | 12 |
Website Links
| baxterpi.com/pi-pdf/Vanco(..) | |
| Disclaimer: Baxter Healthcare Corporation does not review or control the content of any non-Baxter site. Baxter Healthcare Corporation does not endorse and is not responsible for the accuracy, content, practices or standards of any non-Baxter sources. | |
Reimbursement Information
| HCPCS Code | HCPCS Descriptor |
| J3370 | INJECTION, VANCOMYCIN HCL, 500 MG |
| A4216 | STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML |
| Medication Delivery Reimbursement Hotline | 888-338-0001 |
| Information Source: CMS Disclaimer: The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies. |
|
